Health Care Policy

Exacerbating the health care divide

With rates of diagnoses and death disproportionately affecting racial minorities and low-income workers, experts from the School of Arts & Sciences address how COVID-19 has further exposed already dire health outcome inequalities.

From OMNIA

A new vision for the Population Aging Research Center

For more than 25 years, PARC has been a hub for work on disparities in aging and mortality. Co-directors Hans-Peter Kohler and Norma Coe, who took over in July, want to expand its reach.

Michele W. Berger

Aging and the costs that come with it

As a high school student, junior Darcey Hookway spent time volunteering on a dementia ward at a local hospital. “The social aspect of their condition really struck me,” says Hookway, who is from London. “They struggled immensely with social isolation. And now with COVID exacerbating that more than ever, I think that’s a huge detriment to their health.”

Katherine Unger Baillie



In the News


The Hill

It’s time to end the Medicare-Medicaid merry-go-round

In an opinion essay, Rachel M. Werner of the Leonard Davis Institute, Wharton School, and Perelman School of Medicine says that Medicare and Medicaid fail to integrate coverage and coordinate care across their two plans.

FULL STORY →



Time

https://tinyurl.com/mwbnr9xk

Diane Alexander of the Wharton School says that medical reimbursements for an identical office visit in 2009 ranged from $37 in Minnesota to $160 in Alaska.

FULL STORY →



Time

Why maternity care is underpaid

Diane Alexander of the Wharton School says that medical reimbursements for an identical office visit in 2009 ranged from $37 in Minnesota to $160 in Alaska.

FULL STORY →



The New Yorker

How to die in good health

PIK Professor Ezekiel Emanuel says that incessantly preparing for old age mistakes a long life for a worthwhile one.

FULL STORY →



Associated Press

Many cancer drugs remain unproven five years after accelerated approval, a study finds

PIK Professor Ezekiel Emanuel says that there should be definitive benefits to cancer drugs five years after their initial accelerated approval.

FULL STORY →



Philadelphia Inquirer

The influence of private equity on Philly-area doctors’ practices is growing. A new study offers insight

Experts on a panel at the Leonard Davis Institute last year said that private equity-backed health care businesses should not have special rules for issues like reimbursement and transparency.

FULL STORY →